Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Oct 2011;55(4):920-32
Mol Aspects Med 30 , 1-12 (2009)
Important Warnings Liraglutide should be used cautiously in patients with: History of pancreatitis Severe gastrointestinal disease Kidney impairment Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Patient Disclaimer This information is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment
February 25, 2026: Zepbound Label Updated with Warning of Severe Gastrointestinal Issues The FDA has posted an updated Zepbound warning label, which includes reports of gastrointestinal issues that patients claim they experienced after Zepbound reached the market
Maintain Ideal Storage Temperatures GLP-1 medications often require refrigeration
